Zebrafish as a tool in Alzheimer's disease research

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 3, 2011, Pages 346-352

  Newman, Morgan ^a   Verdile, Giuseppe ^b   Martins, Ralph N ^b   Lardelli, M ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b EDITH COWAN UNIVERSITY   (Australia)

Author keywords

Alzheimer's disease; Presenilin; Zebrafish

Indexed keywords

APOLIPOPROTEIN E; CLATHRIN ASSEMBLY PROTEIN; CLUSTERIN; NICASTRIN; PRESENILIN 1; PRESENILIN 2; TAU PROTEIN;

ALZHEIMER DISEASE; GENE MUTATION; MEDICAL RESEARCH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; TRANSGENIC ANIMAL; ZEBRA FISH;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; ZEBRAFISH;

ANIMALIA; DANIO RERIO; VERTEBRATA;

EID: 78751705313     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.09.012     Document Type: Review

References (81)

1. Ferri C.P., Prince M., Brayne C., Brodaty H., Fratiglioni L., Ganguli M., Hall K., Hasegawa K., Hendrie H., Huang Y., Jorm A., Mathers C., Menezes P.R., Rimmer E., Scazufca M. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117.
2. Voisin T., Vellas B. Diagnosis and treatment of patients with severe Alzheimer's disease. Drugs Aging 2009, 26:135-144.
3. Alzheimer A., Stelzmann R.A., Schnitzlein H.N., Murtagh F.R. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde". Clin. Anat. 1995, 8:429-431.
4. Duyckaerts C., Delatour B., Potier M.C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009, 118:5-36.
5. Martins I.J., Hone E., Foster J.K., Sunram-Lea S.I., Gnjec A., Fuller S.J., Nolan D., Gandy S.E., Martins R.N. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer's disease and cardiovascular disease. Mol. Psychiatry 2006, 11:721-736.
6. Rademakers R., Rovelet-Lecrux A. Recent insights into the molecular genetics of dementia. Trends Neurosci. 2009, 32:451-461.
7. Lambert J.C., Heath S., Even G., Campion D., Sleegers K., Hiltunen M., Combarros O., Zelenika D., Bullido M.J., Tavernier B., Letenneur L., Bettens K., Berr C., Pasquier F., Fievet N., Barberger-Gateau P., Engelborghs S., De Deyn P., Mateo I., Franck A., Helisalmi S., Porcellini E., Hanon O., de Pancorbo M.M., Lendon C., Dufouil C., Jaillard C., Leveillard T., Alvarez V., Bosco P., Mancuso M., Panza F., Nacmias B., Bossu P., Piccardi P., Annoni G., Seripa D., Galimberti D., Hannequin D., Licastro F., Soininen H., Ritchie K., Blanche H., Dartigues J.F., Tzourio C., Gut I., Van Broeckhoven C., Alperovitch A., Lathrop M., Amouyel P. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 2009, 41:1047-1048.
8. Harold D., Abraham R., Hollingworth P., Sims R., Gerrish A., Hamshere M.L., Pahwa J.S., Moskvina V., Dowzell K., Williams A., Jones N., Thomas C., Stretton A., Morgan A.R., Lovestone S., Powell J., Proitsi P., Lupton M.K., Brayne C., Rubinsztein D.C., Gill M., Lawlor B., Lynch A., Morgan K., Brown K.S., Passmore P.A., Craig D., McGuinness B., Todd S., Holmes C., Mann D., Smith A.D., Love S., Kehoe P.G., Hardy J., Mead S., Fox N., Rossor M., Collinge J., Maier W., Jessen F., Schurmann B., van den Bussche H., Heuser I., Kornhuber J., Wiltfang J., Dichgans M., Frolich L., Hampel H., Hull M., Rujescu D., Goate A.M., Kauwe J.S., Cruchaga C., Nowotny P., Morris J.C., Mayo K., Sleegers K., Bettens K., Engelborghs S., De Deyn P.P., Van Broeckhoven C., Livingston G., Bass N.J., Gurling H., McQuillin A., Gwilliam R., Deloukas P., Al-Chalabi A., Shaw C.E., Tsolaki M., Singleton A.B., Guerreiro R., Muhleisen T.W., Nothen M.M., Moebus S., Jockel K.H., Klopp N., Wichmann H.E., Carrasquillo M.M., Pankratz V.S., Younkin S.G., Holmans P.A., O'Donovan M., Owen M.J., Williams J. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 2009, 41:1088-1093.
9. Musa A., Lehrach H., Russo V.A. Distinct expression patterns of two zebrafish homologues of the human APP gene during embryonic development. Dev. Genes Evol. 2001, 211:563-567.
10. Joshi P., Liang J.O., Dimonte K., Sullivan J., Pimplikar S.W. Amyloid precursor protein is required for convergent-extension movements during Zebrafish development. Dev. Biol. 2009, 335:1-11.
11. Leimer U., Lun K., Romig H., Walter J., Grunberg J., Brand M., Haass C. Zebrafish (Danio rerio) presenilin promotes aberrant amyloid beta-peptide production and requires a critical aspartate residue for its function in amyloidogenesis. Biochemistry 1999, 38:13602-13609.
12. Newman M., Tucker B., Nornes S., Ward A., Lardelli M. Altering presenilin gene activity in zebrafish embryos causes changes in expression of genes with potential involvement in Alzheimer's disease pathogenesis. J. Alzheimers Dis. 2009, 16:133-147.
13. Nornes S., Groth C., Camp E., Ey P., Lardelli M. Developmental control of Presenilin1 expression, endoproteolysis, and interaction in zebrafish embryos. Exp. Cell Res. 2003, 289:124-132.
14. Nornes S., Newman M., Verdile G., Wells S., Stoick-Cooper C.L., Tucker B., Frederich-Sleptsova I., Martins R., Lardelli M. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity. Hum. Mol. Genet. 2008, 17:402-412.
15. Nornes S., Newman M., Wells S., Verdile G., Martins R.N., Lardelli M. Independent and cooperative action of Psen2 with Psen1 in zebrafish embryos. Exp. Cell Res. 2009, 315:2791-2801.
16. Groth C., Nornes S., McCarty R., Tamme R., Lardelli M. Identification of a second presenilin gene in zebrafish with similarity to the human Alzheimer's disease gene presenilin2. Dev. Genes Evol. 2002, 212:486-490.
17. Chong S.-W., Amsterdam A., Ang H.-W., Yang H., Hopkins N., Jiang Y.-J. Zebrafish Nicastrin is required for mid- and hindbrain development. Dev. Biol. 2009, 331:466.
18. Campbell W.A., Yang H., Zetterberg H., Baulac S., Sears J.A., Liu T., Wong S.T., Zhong T.P., Xia W. Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J. Neurochem. 2006, 96:1423-1440.
19. Zetterberg H., Campbell W.A., Yang H.W., Xia W. The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosis. J. Biol. Chem. 2006, 281:11933-11939.
20. Verdile G., Martins R. Molecular Genetics of Alzheimer's Disease. Molecular Biology of Neuropsychiatric Disorders 2008, 229-276. Springer-Verlag, Berlin. D. Wildenauer (Ed.).
21. Ercelen N., Mercan S. Alzheimer's disease and genes. Adv. Mol. Med. 2005, 1:155-164.
22. Verdile G., Fuller S., Atwood C.S., Laws S.M., Gandy S.E., Martins R.N. The role of beta amyloid in Alzheimer's disease: still a cause of everything or the only one who got caught?. Pharmacol. Res. 2004, 50:397-409.
23. McGowan E., Pickford F., Kim J., Onstead L., Eriksen J., Yu C., Skipper L., Murphy M.P., Beard J., Das P., Jansen K., Delucia M., Lin W.L., Dolios G., Wang R., Eckman C.B., Dickson D.W., Hutton M., Hardy J., Golde T. Abeta42 is essential for parenchymal and vascular amyloid deposition in mice. Neuron 2005, 47:191-199.
24. Chen Q., Nakajima A., Choi S.H., Xiong X., Tang Y.P. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse. J. Neurosci. Res. 2008, 86:1615-1625.
25. Woodruff-Pak D.S. Animal models of Alzheimer's disease: therapeutic implications. J. Alzheimers Dis. 2008, 15:507-521.
26. Oddo S., Caccamo A., Shepherd J.D., Murphy M.P., Golde T.E., Kayed R., Metherate R., Mattson M.P., Akbari Y., LaFerla F.M. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003, 39:409-421.
27. Oakley H., Cole S.L., Logan S., Maus E., Shao P., Craft J., Guillozet-Bongaarts A., Ohno M., Disterhoft J., Van Eldik L., Berry R., Vassar R. Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation. J. Neurosci. 2006, 26:10129-10140.
28. Buxbaum J.N. Animal models of human amyloidoses: are transgenic mice worth the time and trouble?. FEBS Lett. 2009, 583:2663-2673.
29. Wisniewski T. AD vaccines: conclusions and future directions. CNS Neurol. Disord. Drug Targets 2009, 8:160-166.
30. Doody R.S., Gavrilova S.I., Sano M., Thomas R.G., Aisen P.S., Bachurin S.O., Seely L., Hung D. Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer's disease: a randomised, double-blind, placebo-controlled study. Lancet 2008, 372:207-215.
31. Le Guyader S., Jesuthasan S. Analysis of xanthophore and pterinosome biogenesis in zebrafish using methylene blue and pteridine autofluorescence. Pigment Cell Res. 2002, 15:27-31.
32. Yamashita M., Nonaka T., Arai T., Kametani F., Buchman V.L., Ninkina N., Bachurin S.O., Akiyama H., Goedert M., Hasegawa M. Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models. FEBS Lett. 2009, 583:2419-2424.
33. Mackenzie I.R. The neuropathology of FTD associated With ALS. Alzheimer Dis. Assoc. Disord. 2007, 21:S44-S49.
34. Pigino G., Pelsman A., Mori H., Busciglio J. Presenilin-1 mutations reduce cytoskeletal association, deregulate neurite growth, and potentiate neuronal dystrophy and tau phosphorylation. J. Neurosci. 2001, 21:834-842.
35. Takashima A., Murayama M., Murayama O., Kohno T., Honda T., Yasutake K., Nihonmatsu N., Mercken M., Yamaguchi H., Sugihara S., Wolozin B. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:9637-9641.
36. Verdile G., Martins R.N., Duthie M., Holmes E., St George-Hyslop P.H., Fraser P.E. Inhibiting amyloid precursor protein C-terminal cleavage promotes an interaction with presenilin 1. J. Biol. Chem. 2000, 275:20794-20798.
37. Xia W., Ray W.J., Ostaszewski B.L., Rahmati T., Kimberly W.T., Wolfe M.S., Zhang J., Goate A.M., Selkoe D.J. Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:9299-9304.
38. Xia W., Zhang J., Perez R., Koo E.H., Selkoe D.J. Interaction between amyloid precursor protein and presenilins in mammalian cells: implications for the pathogenesis of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:8208-8213.
39. McCarthy J.V., Twomey C., Wujek P. Presenilin-dependent regulated intramembrane proteolysis and gamma-secretase activity. Cell. Mol. Life Sci. 2009, 66:1534-1555.
40. Kang D.E., Soriano S., Xia X., Eberhart C.G., De Strooper B., Zheng H., Koo E.H. Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell 2002, 110:751-762.
41. Tu H., Nelson O., Bezprozvanny A., Wang Z., Lee S.F., Hao Y.H., Serneels L., De Strooper B., Yu G., Bezprozvanny I. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 2006, 126:981-993.
42. Li J., Xu M., Zhou H., Ma J., Potter H. Alzheimer presenilins in the nuclear membrane, interphase kinetochores, and centrosomes suggest a role in chromosome segregation. Cell 1997, 90:917-927.
43. Boeras D.I., Granic A., Padmanabhan J., Crespo N.C., Rojiani A.M., Potter H. Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy. Neurobiol. Aging 2008, 29:319-328.
44. Geller L.N., Potter H. Chromosome missegregation and trisomy 21 mosaicism in Alzheimer's disease. Neurobiol. Dis. 1999, 6:167-179.
45. Malik B., Currais A., Andres A., Towlson C., Pitsi D., Nunes A., Niblock M., Cooper J., Hortobagyi T., Soriano S. Loss of neuronal cell cycle control as a mechanism of neurodegeneration in the presenilin-1 Alzheimer's disease brain. Cell Cycle 2008, 7:637-646.
46. Khandelwal A., Chandu D., Roe C.M., Kopan R., Quatrano R.S. Moonlighting activity of presenilin in plants is independent of gamma-secretase and evolutionarily conserved. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13337-13342.
47. Sotthibundhu A., Sykes A.M., Fox B., Underwood C.K., Thangnipon W., Coulson E.J. Beta-amyloid(1-42) induces neuronal death through the p75 neurotrophin receptor. J. Neurosci. 2008, 28:3941-3946.
48. Newman M., Musgrave I.F., Lardelli M. Alzheimer disease: amyloidogenesis, the presenilins and animal models. Biochim. Biophys. Acta 2007, 1772:285-297.
49. Baumeister R., Leimer U., Zweckbronner I., Jakubek C., Grunberg J., Haass C. Human presenilin-1, but not familial Alzheimer's disease (FAD) mutants, facilitate Caenorhabditis elegans Notch signalling independently of proteolytic processing. Genes Funct. 1997, 1:149-159.
50. Li X., Greenwald I. HOP-1, a Caenorhabditis elegans presenilin, appears to be functionally redundant with SEL-12 presenilin and to facilitate LIN-12 and GLP-1 signaling. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:12204-12209.
51. Link C.D. Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:9368-9372.
52. Crowther D.C., Kinghorn K.J., Miranda E., Page R., Curry J.A., Duthie F.A., Gubb D.C., Lomas D.A. Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease. Neuroscience 2005, 132:123-135.
53. Bharadwaj P., Waddington L., Varghese J., Macreadie I.G. A new method to measure cellular toxicity of non-fibrillar and fibrillar Alzheimer's Abeta using yeast. J. Alzheimers Dis. 2008, 13:147-150.
54. Ravi V., Venkatesh B. Rapidly evolving fish genomes and teleost diversity. Curr. Opin. Genet Dev. 2008, 18:544-550.
55. Peterson K.J., Lyons J.B., Nowak K.S., Takacs C.M., Wargo M.J., McPeek M.A. Estimating metazoan divergence times with a molecular clock. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6536-6541.
56. Chen M., Martins R.N., Lardelli M. Complex splicing and neural expression of duplicated tau genes in zebrafish embryos. J. Alzheimers Dis. 2009, 18:305-317.
57. Paquet D., Bhat R., Sydow A., Mandelkow E.M., Berg S., Hellberg S., Falting J., Distel M., Koster R.W., Schmid B., Haass C. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J. Clin. Invest. 2009, 119:1382-1395.
58. Citron M., Oltersdorf T., Haass C., McConlogue L., Hung A.Y., Seubert P., Vigo-Pelfrey C., Lieberburg I., Selkoe D.J. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 1992, 360:672-674.
59. Lee J.A., Cole G.J. Generation of transgenic zebrafish expressing green fluorescent protein under control of zebrafish amyloid precursor protein gene regulatory elements. Zebrafish 2007, 4:277-286.
60. Shakes L.A., Malcolm T.L., Allen K.L., De S., Harewood K.R., Chatterjee P.K. Context dependent function of APPb enhancer identified using enhancer trap-containing BACs as transgenes in zebrafish. Nucleic Acids Res. 2008, 36:6237-6248.
61. Dorsky R.I., Raible D.W., Moon R.T. Direct regulation of nacre, a zebrafish MITF homolog required for pigment cell formation, by the Wnt pathway. Genes Dev. 2000, 14:158-162.
62. Ratovitski T., Slunt H.H., Thinakaran G., Price D.L., Sisodia S.S., Borchelt D.R. Endoproteolytic processing and stabilization of wild-type and mutant presenilin. J. Biol. Chem. 1997, 272:24536-24541.
63. Prihar G., Fuldner R.A., Perez-Tur J., Lincoln S., Duff K., Crook R., Hardy J., Philips C.A., Venter C., Talbot C., Clark R.F., Goate A., Li J., Potter H., Karran E., Roberts G.W., Hutton M., Adams M.D. Structure and alternative splicing of the presenilin-2 gene. Neuroreport 1996, 7:1680-1684.
64. Walter J., Capell A., Grunberg J., Pesold B., Schindzielorz A., Prior R., Podlisny M.B., Fraser P., Hyslop P.S., Selkoe D.J., Haass C. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the endoplasmic reticulum. Mol. Med. 1996, 2:673-691.
65. Shen J., Bronson R.T., Chen D.F., Xia W., Selkoe D.J., Tonegawa S. Skeletal and CNS defects in Presenilin-1-deficient mice. Cell 1997, 89:629-639.
66. Wong P.C., Zheng H., Chen H., Becher M.W., Sirinathsinghji D.J., Trumbauer M.E., Chen H.Y., Price D.L., Van der Ploeg L.H., Sisodia S.S. Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm. Nature 1997, 387:288-292.
67. Donoviel D.B., Hadjantonakis A.K., Ikeda M., Zheng H., Hyslop P.S., Bernstein A. Mice lacking both presenilin genes exhibit early embryonic patterning defects. Genes Dev. 1999, 13:2801-2810.
68. Steiner H., Duff K., Capell A., Romig H., Grim M.G., Lincoln S., Hardy J., Yu X., Picciano M., Fechteler K., Citron M., Kopan R., Pesold B., Keck S., Baader M., Tomita T., Iwatsubo T., Baumeister R., Haass C. A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling. J. Biol. Chem. 1999, 274:28669-28673.
69. Herreman A., Hartmann D., Annaert W., Saftig P., Craessaerts K., Serneels L., Umans L., Schrijvers V., Checler F., Vanderstichele H., Baekelandt V., Dressel R., Cupers P., Huylebroeck D., Zwijsen A., Van Leuven F., De Strooper B. Presenilin 2 deficiency causes a mild pulmonary phenotype and no changes in amyloid precursor protein processing but enhances the embryonic lethal phenotype of presenilin 1 deficiency. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:11872-11877.
70. van Tijn P., Paridaen J.T., van Rooijen C., Zivkovic D. Zebrafish models for familial Alzheimer's disease. 6th European Zebrafish Genetics and Development Meeting 2009, Rome.
71. Zivkovic D. Investigator profile: an interview with Danica Zivkovic, Ph.D. Zebrafish 2007, 4:1-8.
72. Thinakaran G., Harris C.L., Ratovitski T., Davenport F., Slunt H.H., Price D.L., Borchelt D.R., Sisodia S.S. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 1997, 272:28415-28422.
73. Mann D.M., Takeuchi A., Sato S., Cairns N.J., Lantos P.L., Rossor M.N., Haltia M., Kalimo H., Iwatsubo T. Cases of Alzheimer's disease due to deletion of exon 9 of the presenilin-1 gene show an unusual but characteristic beta-amyloid pathology known as "cotton wool" plaques. Neuropathol. Appl. Neurobiol. 2001, 27:189-196.
74. Kwok J.B., Halliday G.M., Brooks W.S., Dolios G., Laudon H., Murayama O., Hallupp M., Badenhop R.F., Vickers J., Wang R., Naslund J., Takashima A., Gandy S.E., Schofield P.R. Presenilin-1 mutation L271V results in altered exon 8 splicing and Alzheimer's disease with non-cored plaques and no neuritic dystrophy. J. Biol. Chem. 2003, 278:6748-6754.
75. Wolfe M.S. When loss is gain: reduced presenilin proteolytic function leads to increased Abeta42/Abeta40. Talking Point on the role of presenilin mutations in Alzheimer disease. EMBO Rep. 2007, 8:136-140.
76. van Leeuwen F.W., de Kleijn D.P., van den Hurk H.H., Neubauer A., Sonnemans M.A., Sluijs J.A., Koycu S., Ramdjielal R.D., Salehi A., Martens G.J., Grosveld F.G., Peter J., Burbach H., Hol E.M. Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 1998, 279:242-247.
77. Meshorer E., Soreq H. Pre-mRNA splicing modulations in senescence. Aging Cell 2002, 1:10-16.
78. Dovey H.F., John V., Anderson J.P., Chen L.Z., de Saint Andrieu P., Fang L.Y., Freedman S.B., Folmer B., Goldbach E., Holsztynska E.J., Hu K.L., Johnson-Wood K.L., Kennedy S.L., Kholodenko D., Knops J.E., Latimer L.H., Lee M., Liao Z., Lieberburg I.M., Motter R.N., Mutter L.C., Nietz J., Quinn K.P., Sacchi K.L., Seubert P.A., Shopp G.M., Thorsett E.D., Tung J.S., Wu J., Yang S., Yin C.T., Schenk D.B., May P.C., Altstiel L.D., Bender M.H., Boggs L.N., Britton T.C., Clemens J.C., Czilli D.L., Dieckman-McGinty D.K., Droste J.J., Fuson K.S., Gitter B.D., Hyslop P.A., Johnstone E.M., Li W.Y., Little S.P., Mabry T.E., Miller F.D., Audia J.E. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J. Neurochem. 2001, 76:173-181.
79. Geling A., Steiner H., Willem M., Bally-Cuif L., Haass C. A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 2002, 3:688-694.
80. Yang T., Arslanova D., Gu Y., Augelli-Szafran C., Xia W. Quantification of gamma-secretase modulation differentiates inhibitor compound selectivity between two substrates Notch and amyloid precursor protein. Mol. Brain 2008, 1:15.
81. Newman M., Wilson L., Camp E., Verdile G., Martins R.N., Lardelli M. A zebrafish melanophore model of amyloidbeta toxicity. Zebrafish 2010, 7:155-159.